SOLVENTUM CORPORATION Revenue Breakdown
No Revenue Breakdown for SOLV on this site yet.
- 2025-12-31: Others Not split by product in the filing$8.32B100.00%; Total revenue $8.32B.
- 2024-12-31: Others Not split by product in the filing$8.25B100.00%; Total revenue $8.25B.
- 2023-12-31: Others Not split by product in the filing$8.20B100.00%; Total revenue $8.20B.
- 2022-12-31: Others Not split by product in the filing$8.13B100.00%; Total revenue $8.13B.
Source checked: the stored Revenue Breakdown page for SOLV.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $8.32B 100.00% | $8.32B |
| 2024-12-31 | Not split by product in the filing $8.25B 100.00% | $8.25B |
| 2023-12-31 | Not split by product in the filing $8.20B 100.00% | $8.20B |
| 2022-12-31 | Not split by product in the filing $8.13B 100.00% | $8.13B |
Each quarter (3 month)
| Quarter end | Products | Cost Of Software and Rentals | Others | Total revenue |
|---|---|---|---|---|
| 2026-06-30 | $1.70B 76.87% | $511.00M 23.13% | $2.21B | |
| 2026-03-31 | Not split by product $2.01B 100.00% | $2.01B | ||
| 2025-12-31 | Not split by product $2.00B 100.00% | $2.00B | ||
| 2025-09-30 | Not split by product $2.10B 100.00% | $2.10B | ||
| 2025-06-30 | $1.67B 77.19% | $493.00M 22.81% | $2.16B | |
| 2025-03-31 | Not split by product $2.07B 100.00% | $2.07B | ||
| 2024-12-31 | Not split by product $2.08B 100.00% | $2.08B | ||
| 2024-09-30 | Not split by product $2.08B 100.00% | $2.08B | ||
| 2024-06-30 | Not split by product $2.08B 100.00% | $2.08B | ||
| 2024-03-31 | Not split by product $2.02B 100.00% | $2.02B | ||
| 2023-12-31 | Not split by product $2.04B 100.00% | $2.04B | ||
| 2023-09-30 | Not split by product $2.07B 100.00% | $2.07B | ||
| 2023-06-30 | Not split by product $2.08B 100.00% | $2.08B | ||
| 2023-03-31 | Not split by product $2.01B 100.00% | $2.01B |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |